Dorian Paul LeBlanc - 10 Mar 2026 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Reporting relationship: Chief Financial Officer
Issuer ticker: LMAT
Reported as of: 10 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 12 Mar 2026, 16:12:03 UTC
Prior SEC filing: 11 Dec 2025
Next SEC filing: 30 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Laurie A. Churchill, Attorney-in-fact

Key filing fact

Dorian Paul LeBlanc filed Form 4 for LEMAITRE VASCULAR INC (LMAT) on 12 Mar 2026.

Key facts

This page summarizes Dorian Paul LeBlanc's Form 4 filing for LEMAITRE VASCULAR INC (LMAT).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 12 Mar 2026, 16:12.

Change

Previous filing in this sequence was filed on 11 Dec 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002061481 Primary reporting owner

LeBlanc Dorian Paul

Relationship: Chief Financial Officer
Address: C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON
Signature: /s/ Laurie A. Churchill, Attorney-in-fact
Signature date: 12 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LMAT transaction

Common Stock

Options Exercise

Transaction value
Shares: +2
Change %: +0.08%
Price: $0.000000^*
Shares after: 2,400
Date: 10 Mar 2026
Ownership: Direct
Footnotes: F1

LMAT transaction

Common Stock

Tax liability

Transaction value
Shares: -96
Change %: -4%
Price: $109.20^*
Shares after: 2,302
Date: 10 Mar 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LMAT transaction Derivative

Dividend Equivalent Rights

Options Exercise

Transaction value
Shares: -2
Change %: -18%
Price: $0.000000^*
Shares after: 9
Date: 10 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2
Exercise price
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

Footnote F2

These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on March 10, 2025. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.

Footnote F3

These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on March 10, 2025. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.